Fr Vijay Lobo Earns PhD for Innovative Oral Cancer Research

Fr Vijay Lobo, principal of Anugraha Pre-University College in Ujire, has been awarded a Doctor of Philosophy (PhD) degree by PRIST University in Thanjavur. His doctoral research focused on the potential effects of theaflavin and its derivatives on oral cancer, presenting findings from both laboratory and animal studies.

The thesis, titled “The potential effects of theaflavin and its derivative on oral cancer: In vitro and in vivo studies,” explores the therapeutic possibilities of theaflavin compounds in the treatment of oral cancer. This significant research contributes to the understanding of how these compounds may offer new avenues for cancer treatment.

Fr Lobo conducted his research under the mentorship of Dr Bhakrudeen Ali Ahmed, a professor in the Department of Biochemistry at PRIST University. His dedication to education and research reflects a commitment to advancing knowledge in the field of health sciences.

Career and Contributions

A priest of the Mangalore Diocese, Fr Lobo is recognized for his longstanding commitment to education. Before taking on the role of principal at Anugraha Pre-University College, he held leadership positions at Milagres PU College in Kallianpur and St Philomena PU College in Puttur. His contributions to the academic community have left a lasting impact on the institutions he has served.

Fr Lobo’s achievement has been met with congratulations from colleagues and well-wishers, who commend both his academic success and his contributions to cancer research. This recognition underscores the importance of innovative research in addressing critical health challenges, particularly in oncology.

The study of compounds like theaflavin, known for its presence in tea, and its potential benefits in treating oral cancer is a promising area of research. As Fr Lobo continues to engage with the academic and scientific communities, his work may pave the way for future advancements in cancer therapies.

In conclusion, Fr Vijay Lobo’s recent PhD award marks a significant milestone not only in his career but also in the ongoing fight against oral cancer. His research offers hope for new treatment options that could improve patient outcomes in the future.